Protocols
1 protocol(s) meet the specified criteria
Drug: MK-3475
Protocol No.TitleStatus
S1404-CIRB-MK-3475-053S1404: A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma Open